33 recruiting, 30 completed, 15 terminated, 7 active not recruiting. 34 Phase 1, 32 Phase 2, 15 Not applicable, 12 Early Phase 1, 1 Phase 4.
Follow High Grade Glioma: new trials by email Literature Review of High Grade Glioma trials Research Report on High Grade Glioma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Metronomic Temozolomide With Dexbrompheniramine for Recurrent High-Grade Glioma/Glioblastoma Dexbrompheniramine, Temozolomide - High Grade Glioma, Glioblastoma | Phase 1 / Phase 2 | Not yet recruiting | University of Nebraska | 41 | 2027-06-01 | 2026-10-05 |
| Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPG Opdualag - High Grade Glioma, Diffuse Intrinsic Pontine Glioma | Phase 2 | Not yet recruiting | Nationwide Children's Hospital | 12 | 2027-03-01 | 2026-09-09 |
| Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG) Tovorafenib - High Grade Glioma (HGG) of the Brain With BRAF Aberration, High Grade Glioma (III or IV) | Phase 2 | Not yet recruiting | Nationwide Children's Hospital | 79 | 2027-02-01 | 2026-10-20 |
| A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors NEO100 - Pediatric Tumor of CNS, Pediatric Tumor of Brain | Phase 1 | Recruiting | Neonc Technologies, Inc. | 12 | 2026-09-08 | 2026-09-15 |
| Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma LMP744, Conventional Surgery or Biopsy - Recurrent Glioblastoma, Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype | Phase 1 / Phase 2 | Recruiting | National Institute of Neurological Disorders and Stroke (NINDS) | 40 | 2026-07-15 | 2026-10-16 |
| A Clinical Trial Evaluating the Tolerability, Safety, and Preliminary Efficacy of NRG-103 Injection in Patients With Recurrent or Progressive High-grade Glioma NRG-103 - HGG, High Grade Glioma (III or IV) | Phase 1 | Recruiting | Neuregen Therapeutics Co., Ltd. | 24 | 2026-07-09 | 2026-07-17 |
| Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors DNX-2401 - High Grade Glioma, Ependymoma | Phase 2 | Recruiting | Clinica Universidad de Navarra, Universidad de Navarra | 39 | 2026-05-12 | 2026-05-27 |
| Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors Entrectinib, Cyclophosphamide, Etoposide - High Grade Glioma, CNS Tumor | Phase 2 | Recruiting | St. Jude Children's Research Hospital | 52 | 2026-05-01 | 2026-11-03 |
| Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG) Nivolumab, Nivolumab-IRDye800 - Brain Cancer, HGG | Early Phase 1 | Recruiting | Eben Rosenthal | 38 | 2026-03-27 | 2026-07-01 |
| Use of Fluorescence in Gliomas data collection - High Grade Glioma, Glioblastoma | Completed | Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria | 41 | 2025-09-15 | 2026-03-30 | |
| HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma Biological G207 - Neoplasms, High Grade Glioma | Phase 2 | Withdrawn | Pediatric Brain Tumor Consortium | 2025-09-01 | 2026-02-10 | |
| Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion Lorlatinib, Lorlatinib with chemotherapy1, Lorlatinib with chemotherapy 2 - High Grade Glioma, Diffuse Intrinsic Pontine Glioma | Early Phase 1 | Recruiting | Nationwide Children's Hospital | 15 | 2025-08-03 | 2026-06-29 |
| STARLITE for Unresectable High-Grade Gliomas Magnetic Resonance (MR)-guided Laser Interstitial Thermal Therapy (LITT), Abacavir, Lamivudine - High Grade Glioma | Phase 1 | Recruiting | University of Miami | 24 | 2025-04-15 | 2026-06-25 |
| MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas Trametinib and Nivolumab, Dabrafenib, trametinib, nivolumab - Low Grade Glioma, High Grade Glioma | Phase 1 / Phase 2 | Recruiting | Ann & Robert H Lurie Children's Hospital of Chicago | 27 | 2025-04-01 | 2026-07-10 |
| Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells NK cells - High Grade Glioma | Phase 1 | Recruiting | Nationwide Children's Hospital | 18 | 2025-03-04 | 2025-05-13 |
| Study of Olutasidenib and Temozolomide in HGG Olutasidenib + TMZ - High Grade Glioma, Astrocytoma | Phase 2 | Recruiting | Rigel Pharmaceuticals | 60 | 2025-02-01 | 2026-09-01 |
| DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma DB107-RRV, DB107-FC, Radiation Therapy (RT) - High Grade Glioma, MGMT-Unmethylated Glioblastoma | Phase 1 / Phase 2 | Recruiting | University of California, San Francisco | 70 | 2025-01-08 | 2026-03-11 |
| A Pilot Study Investigating Upfront Adaptive Immunotherapy Approach in Children, Adolescent and Young Adult (CAYA) Patients With Replication-Repair Deficient (RRD) High-Grade Gliomas (HGG) Nivolumab, Radiation - High Grade Glioma, Replication Repair Deficient | Not applicable | Recruiting | Daniel Morgenstern | 20 | 2024-12-06 | 2025-08-29 |
| Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant Ribociclib, Everolimus, Temozolomide (TMZ) - High Grade Glioma, Diffuse Intrinsic Pontine Glioma | Phase 2 | Recruiting | Nationwide Children's Hospital | 120 | 2024-08-22 | 2026-05-29 |
| 18F-Fluciclovine PET-MRI in High-grade Glioma 18F-Fluciclovine PET-MRI - Glioma, High Grade Glioma | Early Phase 1 | Recruiting | Children's Hospital of Philadelphia | 30 | 2024-08-07 | 2025-12-04 |
Showing 20 of 98. Sign in to see all of them.
Glioma (98) · Glioblastoma (39) · Brain Neoplasms (28) · Astrocytoma (18) · Diffuse Intrinsic Pontine Glioma (17) · Central Nervous System Neoplasms (7) · Neoplasms (7) · Ependymoma (4) · Medulloblastoma (4) · Recurrence (4) · Gliosarcoma (3) · Melanoma (3) · Neoplasms, Germ Cell and Embryonal (3) · Oligodendroglioma (3) · Carcinoma, Non-Small-Cell Lung (2)
Neoplasms, Glandular and Epithelial (98) · Neoplasms by Histologic Type (97) · Neoplasms, Nerve Tissue (97) · Neoplasms, Neuroepithelial (97) · Neuroectodermal Tumors (97) · Neoplasms, Germ Cell and Embryonal (95) · Neoplasms (91) · Neoplasms by Site (44) · Nervous System Diseases (42) · Nervous System Neoplasms (42) · Brain Diseases (40) · Central Nervous System Diseases (40) · Central Nervous System Neoplasms (35) · Astrocytoma (24) · Infratentorial Neoplasms (18)
Temozolomide (14) · Radiotherapy (9) · Nivolumab (6) · Blood Specimen Collection (3) · Everolimus (3) · Magnetic Resonance Spectroscopy (3) · ribociclib (3) · Aminolevulinic Acid (2) · Blood Component Removal (2) · Congresses as Topic (2) · Diphtheria-Tetanus Vaccine (2) · Flucytosine (2) · Granulocyte-Macrophage Colony-Stimulating Factor (2) · Imiquimod (2) · Leukapheresis (2)
Nationwide Children's Hospital (10) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (5) · National Cancer Institute (NCI) (3) · Case Comprehensive Cancer Center (2) · Children's Hospital Medical Center, Cincinnati (2) · Nader Sanai (2) · Northwell Health (2) · St. Jude Children's Research Hospital (2) · University of California, San Francisco (2) · University of Florida (2) · Alberta Health services (1) · Alpheus Medical, Inc. (1) · Ann & Robert H Lurie Children's Hospital of Chicago (1) · Ashish Shah (1) · Assistance Publique - Hôpitaux de Paris (1)
United States (65) · Canada (11) · Germany (8) · Netherlands (8) · Australia (7) · Italy (7) · China (5) · France (5) · New Zealand (5) · United Kingdom (5) · Spain (4) · Japan (3) · Austria (2) · Belgium (2) · Brazil (2)
Maryam Fouladi, MD (7) · Margot Lazow, MD (4) · Nader Sanai, MD (3) · Stuart A Grossman, MD (3) · Ashish Shah, MD (2) · Elias Sayour, MD, PhD (2) · Jennifer Yu, MD, PhD (2) · John Boockvar, MD (2) · Macarena De La Fuente, MD (2) · Nicholas Butowski, MD (2) · Susan Chi, MD (2) · Albert Murtha, MD (1) · Alberto Valarezo Chuchuca, MD (1) · Alireza Mansouri, MD MSc FRCSC (1) · Andrew Brenner, MD, (1)
PMID 41213248, PMID 26843484, PMID 27098749, PMID 29412784, PMID 29763623, PMID 30819765, PMID 31399142, PMID 31419298, PMID 32354716, PMID 32603316, PMID 33034839, PMID 33859944, PMID 34025640, PMID 34101090, PMID 35412366, PMID 35791008, PMID 38049523, PMID 38503417, PMID 38537315, PMID 38771986, PMID 38968568, PMID 40025673, PMID 40225909, PMID 40875628, PMID 41218853, PMID 41296829, PMID 41544350
2018 (2), UM1CA137443 (2), 2017 (1), 2023 (1), P30CA012197 (1), R01CA195563 (1), R21CA186140 (1), R21CA282543 (1), U01CA062475 (1), UM1CA081457 (1)